Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes

Publication Description
Abstract Background Skin collagen Long Wavelength Fluorescence (LWF) is widely used as a surrogate marker for accumulation of advanced glycation end-products. Here we determined the relationship of LWF with glycemia, skin fluorescence, and the progression of complications during EDIC in 216 participants from the DCCT. Methods LW-1 and collagen-linked fluorescence (CLF) were measured by either High Performance Liquid Chromatography (HPLC) with fluorescence detection (LW-1) or total fluorescence of collagenase digests (CLF) in insoluble skin collagen extracted from skin biopsies obtained at the end of the DCCT (1993). Skin intrinsic fluorescence (SIF) was noninvasively measured on volar forearm skin at EDIC year 16 by the SCOUT DS instrument. Results LW-1 levels significantly increased with age and diabetes duration (P 3 sustained microaneurysms, P = 0.0004) and albumin excretion rate (P = 0.0038), the latter despite adjustment for HbA1c. Comparative analysis for all three fluorescent measures for future risk of subclinical macrovascular disease revealed the following significant (P

Primary Author
Sell,David
Wanjie Sun
Xiaoyu Gao
Strauch,Christopher
Lachin,John
Cleary,Patricia
Genuth,Saul
Monnier,Vincent

Publisher
Figshare

URL
https://search.datacite.org/works/10.6084/m9.figshare.c.3620714.v1

Edition
https://search.datacite.org/works/10.6084/m9.figshare.c.3620714.v1



Reference Type
Web Page

Publication Year
2016

Document Object Index
10.6084/m9.figshare.c.3620714.v1